COSMOS Pharmaceutical Corporation

3349・Prime Market・Retail Trade

Official website

COSMOS Pharmaceutical Corporation

3349・Prime Market・Retail Trade

Official website

COSMOS Pharmaceutical Corporation3349

Reference Indicators

Market Cap

5,000¥100M

P/E (Forecast)

—

P/B

1.7x

Dividend Yield (Forecast)

1.34%

ROE

11.8%

EV/EBITDA

7.6x

Financial Summary

Unit: ¥M

Item	2022May 2022	2023May 2023	2024May 2024	2025May 2025	2026May 2026
Net Sales	755,414	827,697	964,989	1,011,390	1,099,583
Cost of Sales	603,966	658,979	776,683	798,109	869,900
Gross Profit	151,447	168,718	188,305	213,281	229,683
SG&A Expenses	121,651	138,589	156,804	172,877	187,330
Operating Income	29,796	30,128	31,501	40,404	42,353
Non-operating Income	3,695	3,677	3,637	3,744	3,435
Non-operating Expenses	629	719	839	988	1,174
Ordinary Income	32,861	33,086	34,299	43,160	44,614
Extraordinary Income	502	46	628	15	214
Extraordinary Losses	315	359	1,208	803	610
Pre-tax Income	33,048	32,773	33,719	42,372	44,218
Income Taxes	9,892	8,975	9,265	11,393	12,171
Net Income	23,155	23,797	24,454	30,978	32,046
EBITDA	44,906	47,496	51,425	62,633	66,929
Gross Margin	20.0%	20.4%	19.5%	21.1%	20.9%
Operating Margin	3.9%	3.6%	3.3%	4.0%	3.9%
ROA	6.4%	5.7%	5.1%	5.9%	5.4%
ROE	12.8%	11.9%	11.1%	12.7%	11.8%